SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending as its announcement of a $250 million financing amendment, extending its capital runway to 2028, sparks intense debate; bullish traders anticipate a massive short squeeze reminiscent of past parabolic moves, while skeptics raise concerns about potential dilution from the equity line of credit.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is actively discussed as its newly inaugurated Eagle Line pilot production facility highlights its transition towards scalable solid-state battery manufacturing, driving community excitement for future OEM partnerships and impending updates on commercialization and revenue timelines.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is actively discussed as it navigates the fallout from retracting its compounded weight-loss pill following regulatory scrutiny and legal threats, with the community sharply divided between those foreseeing a significant short squeeze and a rebound based on its broader telehealth offerings, and others concerned about long-term brand damage and potential liabilities.

Rydex Investments - Invesco CurrencyShares British Pound Sterling Trust

Invesco CurrencyShares British Pound Sterling Trust

The Invesco CurrencyShares British Pound Sterling Trust is trending as recent cooler-than-expected UK CPI data has fueled aggressive market expectations for a Bank of England rate cut, driving bearish sentiment for the pound and highlighting central bank policy divergence.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as the community eagerly awaits its Q4 earnings report, with widespread belief in the AI-powered lender's significant undervaluation and the potential for a short squeeze amidst a volatile fintech sector. Investors are also noting recent forward flow agreements and debt repurchases as positive indicators, despite broader market concerns.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

ZETA is trending with significant anticipation surrounding its impending earnings, which many expect to be an 18th consecutive beat-and-raise, as the community actively discusses its robust free cash flow and AI-driven Athena platform as undervalued strengths despite recent market volatility.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is breaking out to new all-time highs, with the community actively discussing how escalating geopolitical tensions in the Middle East and Venezuela are creating a "war premium" on oil and driving significant capital rotation into the energy sector.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as it expands into the premium market with its 30,000th flagship store, challenging rivals like Starbucks, while a major competitor ending aggressive price promotions is sparking community optimism for significantly improved profitability and a potential US relisting.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the recent departure of its CFO sparks community discussion regarding a potential acquisition, amidst persistent shareholder concerns over management and an upcoming European approval decision for Miplyffa.

Invesco DB US Dollar Index Trust - Invesco DB US Dollar Index Bullish Fund

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund (UUP) is trending as widespread expectations for Federal Reserve rate cuts fuel a community debate between continued dollar weakness and its potential for a safe-haven rebound amidst global central bank divergence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coya Therapeutics Announces $11.1 Million Private Placement

Coya Therapeutics, Inc. (Nasdaq: COYA) (Coya or the Company), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with...

D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA)

D. Boral Capital reissued a "buy" rating and set a $15.00 price objective on shares of Coya Therapeutics in a report on Wednesday...

Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to...

Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients

Coya Therapeutics, Inc. (NASDAQ: COYA) (Coya or the Company), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with...

D. Boral Capital Reiterates "Buy" Rating for Coya Therapeutics (NASDAQ:COYA)

D. Boral Capital reissued a "buy" rating and issued a $15.00 price target on shares of Coya Therapeutics in a research report on Monday...

D. Boral Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)

D. Boral Capital restated a "buy" rating and set a $15.00 price objective on shares of Coya Therapeutics in a research report on Tuesday...

Coya Therapeutics Receives Clinical Trial Application (CTA) Acceptance from Health Canada to Proceed with the COYA 302 ALSTARS Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Coya Therapeutics, Inc. (NASDAQ:COYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Coya Therapeutics, Inc. (NASDAQ:COYA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports...

Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated a "buy" rating and set a $15.00 target price on shares of Coya Therapeutics in a research report on Tuesday...

Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$4.84
Prev Close	$4.42
Open	$4.43
Dividend Yield	0.00%
50-Day Moving Average	$5.32
Beta	0.91
Avg. Volume	337,125.65
PE Ratio	-4.39

52-Week High	$8.29
52-Week Low	$3.94
Market Capitalization	$101.27M
EPS (Annual)	-$0.9765
Price to Book	2.97
Revenue Per Employee	$444,257.63
Enterprise Value/EBITDA	N/A

COYA
Coya Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COYA News

COYACoya Therapeutics Inc